サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1543999

デング熱検査の世界市場

Dengue Testing

出版日
ページ情報
英文 158 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デング熱検査の世界市場
出版日: 2024年08月29日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 158 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

デング熱検査の世界市場は2030年までに7億4,080万米ドルに達する見込み

2023年に5億3,100万米ドルと推定されたデング熱検査の世界市場は、2030年には7億4,080万米ドルに達し、分析期間2023-2030年のCAGRは4.9%で成長すると予測されます。本レポートで分析したセグメントの1つである病院の最終用途は、CAGR 5.8%を記録し、分析期間終了までに3億6,780万米ドルに達すると予測されます。診断センターの最終用途セグメントの成長率は、分析期間中CAGR 4.5%と推定されます。

米国市場は1億4,330万米ドルと推定、中国はCAGR8.3%で成長すると予測

米国のデング熱検査市場は、2023年に1億4,330万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億6,130万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは8.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.4％と4.0％と予測されています。欧州では、ドイツがCAGR 3.2%で成長すると予測されています。

世界のデング熱検査市場- 主要動向と促進要因まとめ

デング熱とは何か、なぜ正確な検査が重要なのか？

デング熱は、主に世界中の熱帯・亜熱帯気候で流行している蚊媒介性のウイルス性疾患であり、公衆衛生上の重大な課題となっています。4つのデングウイルス血清型のうちの1つによって引き起こされ、軽度の発熱からインフルエンザのような重篤な症状まで幅広い症状を呈し、重篤な場合はデング出血熱やデングショック症候群に移行し、死に至ることもあります。デング熱の正確な検査は、適切な臨床管理のためだけでなく、病気の蔓延を抑えるためにも極めて重要です。早期診断は、症状をより効果的に管理するのに役立ち、より重篤な病型への進行を抑えることができます。さらに、流行地域においてデング熱を他の発熱性疾患と区別することは、的を絞った公衆衛生対応と効率的な資源配分のために不可欠です。

デング熱検査はどのように行われ、どのような技術が関わっているのか？

デング熱検査には、病気の段階に応じたいくつかの調査手法が含まれます。初期段階では、特異性が高くウイルスの血清型を特定できるRT-PCR検査でウイルスRNAを検出することができます。病気が進行すると、IgM抗体とIgG抗体を区別できるELISA（酵素結合免疫吸着測定法）検査による抗体の検出に焦点が移ります。IgM抗体は通常、症状発現後約5日目から検出可能で、最近の感染を示しますが、IgG抗体はそれ以降に出現し、過去の感染や異なる血清型による二次感染による増強を示すことがあります。迅速診断検査（RDT）も開発されており、一般的に臨床検査に基づく検査よりも特異性は劣るもの、その使いやすさと迅速性から、資源の限られた環境では貴重な検査法となっています。

デング熱検査の課題は何か？

診断技術の進歩にもかかわらず、デング熱検査は大きな課題に直面しています。大きな問題のひとつは、ジカ熱やチクングニア熱など他のフラビウイルスとの交差反応性で、誤診の原因となります。これは、これらのウイルスが共存する地域では特に問題となります。もう1つの課題は、特に迅速診断検査の感度や特異度にばらつきがあることで、偽陰性や偽陽性を引き起こす可能性があります。このような不正確さは、患者のケアや疾病サーベイランスに深刻な影響を及ぼす可能性があります。さらに、ウイルスや抗体を検出できる期間は比較的短いため、タイムリーな検査が必要であるが、遠隔地や十分なサービスを受けていない地域では必ずしも実行可能とは限らないです。このような課題から、デング熱検査法の精度、アクセシビリティ、信頼性を高めるための継続的な研究開発の必要性が浮き彫りになっています。

デング熱検査市場の成長を促進する要因は？

デング熱検査市場の成長は、世界のデング熱の罹患率の上昇をはじめとするいくつかの要因によってもたらされます。世界の旅行者の増加や蚊の繁殖に適した気候条件により、デング熱は従来の地理的境界を越えて拡大しており、診断検査の需要が高まっています。デング熱の蔓延を抑えることに重点を置いた公衆衛生上の取り組みも、特に、より厳格なサーベイランスと制圧対策を実施している流行国において、この需要に拍車をかけています。バイオテクノロジーの進歩により、より迅速で正確、かつ費用対効果の高い検査が開発されるようになったことも、大きな成長促進要因となっています。さらに、デング熱の経済的・健康的影響に対する認識の高まりにより、予防医療や診断に対する公共・民間部門の投資が拡大しています。最後に、COVID-19の大流行は、感染症に対する世界の関心を高め、タイムリーで正確な検査の重要な役割を認識させ、デング熱診断分野への投資と技術革新をさらに加速させました。こうした技術的、経済的、社会的促進要因は、デング熱やその他の媒介性疾患をより効果的に管理するための公衆衛生インフラの改善にますます重点が置かれていることを反映し、市場の堅調な成長を確実なものにしています。

調査対象企業の例（注目の12社）

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Certest Biotec S.L.
  • Euroimmun AG
  • InBios International
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics, Inc.
  • Roche Molecular Systems Inc.
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP11491

Global Dengue Testing Market to Reach US$740.8 Million by 2030

The global market for Dengue Testing estimated at US$531.0 Million in the year 2023, is expected to reach US$740.8 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$367.8 Million by the end of the analysis period. Growth in the Diagnostic Centers End-Use segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$143.3 Million While China is Forecast to Grow at 8.3% CAGR

The Dengue Testing market in the U.S. is estimated at US$143.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$161.3 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Dengue Testing Market - Key Trends and Drivers Summarized

What Is Dengue and Why Is Accurate Testing Crucial?

Dengue fever is a mosquito-borne viral disease prevalent primarily in tropical and subtropical climates worldwide, posing significant public health challenges. Caused by one of the four dengue virus serotypes, it presents a wide range of symptoms from mild fever to severe flu-like conditions, and in critical cases, it can progress to dengue hemorrhagic fever or dengue shock syndrome, which can be fatal. Accurate testing for dengue is crucial not only for appropriate clinical management but also for controlling the spread of the disease. Early diagnosis helps in managing the symptoms more effectively and can reduce the progression to more severe forms. Moreover, distinguishing dengue from other febrile illnesses in endemic regions is essential for targeted public health responses and efficient resource allocation.

How Are Dengue Tests Conducted and What Technologies Are Involved?

Dengue testing involves several methodologies that depend on the stage of the illness. In the early stages, viral RNA can be detected using RT-PCR tests, which are highly specific and can identify the virus serotype. As the disease progresses, the focus shifts to detecting antibodies using ELISA (enzyme-linked immunosorbent assay) tests that can differentiate between IgM and IgG antibodies. IgM antibodies are typically detectable from about five days after the onset of symptoms and indicate a recent infection, while IgG antibodies appear later and can indicate a past infection or enhancement due to secondary infection with a different serotype. Rapid diagnostic tests (RDTs) have also been developed, which are invaluable in resource-limited settings for their ease of use and quick turnaround times, although they generally offer less specificity than laboratory-based tests.

What Are the Challenges in Dengue Testing?

Despite advances in diagnostic technologies, dengue testing faces significant challenges. One major issue is the cross-reactivity with other flaviviruses such as Zika and chikungunya, which can lead to misdiagnosis. This is particularly problematic in regions where these viruses co-circulate. Another challenge is the variation in test sensitivity and specificity, especially among rapid diagnostic tests, which can lead to false negatives or false positives. Such inaccuracies can have severe implications for patient care and disease surveillance. Additionally, the window for detecting the virus or antibodies is relatively short, which necessitates timely testing that may not always be feasible in remote or underserved areas. These challenges underscore the need for ongoing research and development to enhance the accuracy, accessibility, and reliability of dengue testing methods.

What Drives the Growth in the Dengue Testing Market?

The growth in the dengue testing market is driven by several factors, beginning with the rising incidence of dengue worldwide. As global travel increases and climatic conditions favor mosquito breeding, dengue is expanding beyond traditional geographic boundaries, increasing the demand for diagnostic tests. Public health initiatives focused on controlling the spread of dengue also fuel this demand, particularly in endemic countries that are implementing more rigorous surveillance and control measures. Advances in biotechnology that have led to the development of faster, more accurate, and cost-effective tests are also significant growth drivers. Additionally, the growing awareness of the economic and health impacts of dengue has led to greater public and private sector investment in preventive care and diagnostics. Finally, the COVID-19 pandemic has heightened global attention on infectious diseases and the critical role of timely and accurate testing, further accelerating investment and innovation in the field of dengue diagnostics. These technological, economic, and social drivers ensure robust market growth, reflecting an increasing emphasis on improving public health infrastructure to manage dengue and other vector-borne diseases more effectively.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Certest Biotec S.L.
  • Euroimmun AG
  • InBios International
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics, Inc.
  • Roche Molecular Systems Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Dengue Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Dengue Fever Drives Demand for Effective Testing Solutions
    • Growing Public Health Initiatives to Combat Dengue Bolster Testing Market
    • Technological Advancements in Diagnostic Kits Enhance Rapid and Accurate Dengue Detection
    • Expansion of Healthcare Infrastructure in Endemic Regions Spurs Market Growth
    • Increasing Travel and Migration Amplify Risks and Demand for Dengue Testing
    • Expansion of Laboratory and In-Clinic Testing Capacities in Developing Countries
    • Increasing Use of Point-of-Care Testing Devices for Dengue in Remote Areas
    • Rising Demand for Molecular Diagnostic Tests for Early Dengue Detection
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for ELISA-Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for ELISA-Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for ELISA-Based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for RT-PCR Based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Public Health Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Dengue IgG / IgM Rapid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Dengue IgG / IgM Rapid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Dengue IgG / IgM Rapid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Dengue Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Dengue Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Dengue Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Dengue Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Dengue Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Dengue Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION